REG - Fevara PLC - Result of AGM

FevaraAnnouncement

12/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260212:nRSL6741Sa&default-theme=true

RNS Number : 6741S  Fevara PLC  12 February 2026

12 February 2026

Fevara plc

(the "Company" or "Fevara")

 

Result of Annual General Meeting 2026

 

Fevara plc (LSE: FVA), an international specialist in livestock
supplements, confirms that the Annual General Meeting of the Company ("AGM")
was held at 1.00pm (GMT) on 11 February 2026. At the Meeting, the ordinary and
special resolutions set out in the Notice of the Annual General Meeting dated
19 December 2025 were proposed and voted on by way of a poll.  All of the
proposed resolutions were passed.

Full details of the poll results are set out below.

 Issued share capital:  51,783,796

 

 Resolution                                      Number of votes for  % of votes for  Number of votes against  % of votes against  Total votes cast  % of issued share capital  Votes withheld*
 1. Approve Annual Report and Accounts           14,623,675           99.93%          9,996                    0.07%               14,633,671        28.26%                     4,460
 2. Approve final dividend                       14,265,325           97.57%          355,896                  2.43%               14,621,221        28.24%                     16,910
 3. Re-elect Tim Jones                           14,400,563           98.66%          195,997                  1.34%               14,596,560        28.19%                     41,571
 4. Elect Joshua Hoopes                          14,543,663           99.65%          51,416                   0.35%               14,595,079        28.18%                     43,052
 5. Re-elect Stuart Lorimer                      14,384,966           98.70%          189,933                  1.30%               14,574,899        28.15%                     63,232
 6. Re-elect Gillian Watson                      8,406,073            60.74%          5,434,058                39.26%              13,840,131        26.73%                     798,000
 7. Re-elect Fiona Rodford                       14,379,698           98.39%          234,701                  1.61%               14,614,399        28.22%                     23,732
 8. Re-elect Martin Rowland                      14,439,895           98.93%          156,665                  1.07%               14,596,560        28.19%                     41,571
 9. Re-appoint Grant Thornton UK LLP as Auditor  14,578,666           99.75%          36,244                   0.25%               14,614,910        28.22%                     23,221
 10. Authorise remuneration of Auditor           14,590,771           99.82%          26,820                   0.18%               14,617,591        28.23%                     20,540
 11. Approve Remuneration Report                 14,496,298           99.28%          105,433                  0.72%               14,601,731        28.20%                     36,400
 12. Authorise allotment of shares               14,470,880           99.15%          124,339                  0.85%               14,595,219        28.18%                     42,912
 13. Disapply pre-emption (general)              14,401,755           98.66%          195,464                  1.34%               14,597,219        28.19%                     40,912
 14. Disapply pre-emption (investments)          14,455,207           99.03%          142,012                  0.97%               14,597,219        28.19%                     40,912

 

*A "Vote withheld" is not a vote in law and is not counted in the calculation
of the percentage of shares voted "For" or "Against" any resolution.

The Board is always open to constructive dialogue with shareholders and is
grateful to all those who took the time to consider and vote on the
resolutions proposed.  The Board notes that although Resolution 6 was passed
by the requisite majority, 39.26% of votes were cast against.  The Company
will engage with shareholders to fully understand the reasons for this and
provide an update within six months of the AGM as required by
the UK Corporate Governance Code. The Board will then provide a final
summary in the annual report.

A copy of the resolutions passed as Special Business at the AGM have been
submitted to the UK Listing Authority and will be available for public
inspection at the National Storage Mechanism (NSM)
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

Enquiries:

 Fevara plc                                    +44 (0) 1228 554 600

Paula Robertson, Company Secretary

 Canaccord Genuity Limited (Corporate Broker)  +44 (0)20 7523 8000

 Max Hartley / Harry Rees

 Hudson Sandler (PR Adviser)                   +44 (0) 20 7796 4133

 Hattie Dreyfus / Nick Moore

 

About Fevara plc:

 

Fevara is an international specialist in livestock supplements.

 

Fevara's purpose is to empower farmers in extensive grazing systems with
research-proven products that boost profitability, improve resource efficiency
and support sustainable agriculture.  The Group develops, manufactures and
markets research-proven supplements, including feed licks, blocks, bagged
minerals, and boluses for cattle, sheep and horses, sold under recognised and
trusted brands, including Crystalyx(®), HorsLic(®)(,) Horslyx(®), Scotmin
Nutrition(®), SmartLic(®) and Tracesure® Advanced.

 

Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing
sites in the UK, US and Brazil with three operational joint ventures in
Germany and the US. It serves customers in more than 20 countries through its
expansive international distribution and support network.

 

Fevara has been listed on the London Stock Exchange since 1972.

 

For more information, visit: www.fevara.com (http://www.fevara.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSFAESFEMSELE



            Copyright 2019 Regulatory News Service, all rights reserved